John Klimowich, SEVP and Chief Risk Officer of Columbia Financial, Inc./MD/ (NASDAQ:CLBK), filed a Form 4 on November 17, 2026, disclosing a transaction dated November 13, 2026, involving the acquisition of phantom stock units through the Columbia Bank Stock Based Deferral Plan.
Key Highlights
- Acquisition transaction: Klimowich acquired 61.3458 phantom stock units on November 13, 2026, at a price of $11.16 per unit.
- Post-transaction indirect holding: Following the transaction, 20,975.9357 shares are held indirectly through the Stock-Based Deferral Plan.
- Direct ownership: The filing reports 145,056 shares held directly by the reporting person.
- Additional indirect holdings: Klimowich also holds shares indirectly through a 401(k) (67,975), SIM (9,309), ESOP (19,198), SERP (16,852), Stock Award III (24,135), Stock Award IV (25,790), and Stock Award V (26,193).
- Stock options outstanding: Five tranches of stock options are reported, with exercise prices ranging from $7.10 to $8.31, covering a combined 549,234 shares of common stock.
- Non-discretionary purchase: According to the filing, the acquisition represents phantom stock purchased "on a non-discretionary basis, by the trustee of the Bank's rabbi trust" under the Columbia Bank Stock Based Deferral Plan.
Klimowich's November 2026 Deferral Plan Transaction and Beneficial Ownership at Columbia Financial
John Klimowich, identified in the filing as SEVP and Chief Risk Officer of Columbia Financial, Inc./MD/, reported an acquisition of 61.3458 phantom stock units on November 13, 2026, at $11.16 per unit. The filing states this purchase was made "on a non-discretionary basis, by the trustee of the Bank's rabbi trust maintained in connection with the Columbia Bank Stock Based Deferral Plan, a non-qualified stock-based deferral plan." The filing further states that "Stock unit interests under the Columbia Bank Stock Based Deferral Plan will be settled in shares of stock upon distribution to the reporting person." Following this transaction, the total indirect holding under the plan stands at 20,975.9357 shares.
Beyond the deferral plan units, the filing discloses that Klimowich directly holds 145,056 shares of common stock. Indirect holdings are reported across several vehicles: 67,975 shares via a 401(k), 9,309 via SIM, 19,198 via ESOP, 16,852 via SERP, 24,135 via Stock Award III, 25,790 via Stock Award IV, and 26,193 via Stock Award V. The Stock Award tranches were granted under the Columbia Financial, Inc. 2019 Equity Incentive Plan and are subject to time-based and performance-based vesting conditions, as described in the filing's explanatory footnotes.
The filing also reports five tranches of stock options, all held directly. Exercise prices are $7.10, $7.25, $7.50, $7.38, and $8.31, covering 414,117, 26,466, 19,470, 44,682, and 44,499 shares, respectively, with expiration dates ranging from July 23, 2029, to March 2, 2036. The filing notes that the options at $7.10 and $7.25 are fully vested and exercisable, while the remaining three vest in approximately equal annual installments commencing on specified dates.
What Was Disclosed
This Form 4 filed by John Klimowich, SEVP and Chief Risk Officer of NASDAQ:CLBK, discloses the non-discretionary acquisition of 61.3458 phantom stock units at $11.16 on November 13, 2026, through the Columbia Bank Stock Based Deferral Plan, along with a full snapshot of his beneficial ownership in direct and indirect holdings and stock options.



Please wait processing your request...